Breast cancer cells act as ‘arginine factories’ to suppress immune response and drive tumor growth, study finds

Chinese scientists have revealed a hidden metabolic partnership between breast cancer cells and immune cells that drives aggressive tumor behavior and resistance to immunotherapies. The study sheds light on how tumor cells exploit the amino acid arginine to both fuel their growth and evade the immune system.

Leave A Comment

Your email address will not be published. Required fields are marked *